Assurance In Action: Episode 43 Testing

Assurance In Action: Episode 43 Testing is an integrated food safety assurance program that pairs rapid screening with confirmatory analysis. It tests food and feed samples for chemical contaminants, microbial hazards, and authenticity markers using ELISA, HPLC, and PCR. Results are reported against regulatory and client-specific acceptance criteria in an accredited laboratory report.

Scope of the Episode 43 Testing Program

Episode 43 covers a screening-plus-confirmation testing scope for food and feed matrices across the supply chain. Applicable sample categories include raw grains, oils, dairy ingredients, processed foods, and animal feed. The chemical hazard dimension covers contaminants routinely monitored in these matrices. Examples are mycotoxins and veterinary drug residues. The biological dimension covers pathogen screening. It also covers nucleic-acid-based identification of target organisms. A third dimension addresses authenticity. This includes species and GMO marker verification. The scope is broad. The same program logic applies whether a client tests a single raw-material lot or a finished product released for distribution. Work outside this scope, such as packaging migration or environmental monitoring, follows separate program modules and is not described here.

Sample Types and Collection Requirements

Sample validity begins at collection. Consignments are sampled at defined points so each laboratory sample represents the lot from which it is drawn. For chemical analysis, incremental portions are combined, homogenized, and reduced to a laboratory sample. The sample must have enough mass for repeat extraction. For microbiological testing, containers, tools, and sampling surfaces are sterilized before use. Samples are sealed immediately to prevent cross-contamination. Temperature control is maintained in transit. Chilled conditions apply to microbial samples. Frozen conditions protect analytes that degrade at ambient temperature. Each sample carries a unique identifier. The custody record links it to the lot, collector, date, and storage condition. On receipt, the laboratory verifies integrity. It checks holding time against the requested methods and records any deviation before analysis begins.

Core Test Methods — ELISA, HPLC, PCR

Three methods carry the analytical workload. ELISA serves as the first screening tier for chemical hazards. Samples are extracted, diluted, and loaded into antibody-coated microwells. A plate reader converts color development into concentration estimates. Screening processes large sample numbers within one working session. Presumptive positives are routed to confirmation. HPLC provides the confirmatory tier. Extracts are separated on a reversed-phase column with UV or fluorescence detection. Matrix-matched calibration then yields a quantitative value for the flagged analyte. PCR addresses nucleic-acid targets. After DNA extraction, real-time PCR amplifies target sequences. Fluorescence signals indicate pathogens, species markers, or GMO constructs. The workflow is tiered. ELISA filters the sample population. HPLC confirms chemical positives at regulated limits. PCR resolves biological targets directly. Method selection follows the matrix and the parameter set. The laboratory documents each step from extraction to signal integration.

Assay

Performance — Sensitivity and Recovery
Performance is demonstrated through validation data for each matrix-method pair. Sensitivity is expressed as the limit of detection and the limit of quantitation. Results below the quantitation limit are reported as not quantified rather than as numerical values. Recovery is verified by fortifying blank matrix material at defined concentration levels. Measured amounts are compared against added amounts. Acceptable recovery ranges are set by the applied standard. Out-of-range findings trigger review of extraction and cleanup steps. Precision is assessed through repeat analysis of homogeneous material. The relative standard deviation is tracked across batches. Matrix effects shift signals between clean solvents and real extracts. These effects are managed with matrix-matched calibration or standard addition. Control charts record reference-material results over time. Drift becomes visible before it affects reported data.

Co-Testable Parameters and Panels

Panel design reduces cost and turnaround because one sample supports multiple parameters. A single homogenized portion can be split into aliquots for an ELISA panel, an HPLC multi-residue run, and a PCR pathogen panel. No additional client-site sampling is needed. Within the chemical tier, analytes that share extraction behavior and chromatographic response are grouped. One run then quantifies several targets. Within the biological tier, pathogen screening can be arranged as a panel. The panel covers the organisms relevant to a matrix category. Co-testing has constraints. Differences in extraction compatibility, concentration range, and cleanup requirements may force separation into distinct runs. Aliquot planning is documented at receipt. Panel additions then do not require resampling when sufficient mass remains. The laboratory assigns parameters to panels during quotation. The report lists each parameter with its own method reference, detection limit, and result.

Acceptance

Criteria and Reporting Standards
Results are judged against two layers of criteria. The first layer is regulatory. Measured concentrations are compared with the applicable maximum limits for the product and the destination market. The second layer is client-specific. It applies where contractual specifications are stricter than the regulatory floor. ELISA screening results remain presumptive until HPLC confirmation. Confirmed values carry the final compliance statement. A result below the quantitation limit is reported with the applied limit rather than a numerical estimate. The test report identifies the sample and lot. It references the applied methods. It states the detection and quantitation limits, presents the result with its limit comparison, and notes deviations recorded during collection or analysis. Review and authorization by qualified personnel precede release. The report also states the accreditation scope under which the work was performed.